Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026.

GENPHARMASEC LIMITED Date: 29.09.2026 BSE Limited The Compliance Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 531592 Subject: Submission of Proceedings of the 34t4 Annual General Meeting. Dear Sir/ Madam, Pursuant to Regulation 30 read with Part A of Schedule II of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the proceedings of the 34 Annual General Meeting of the Members of Genpharmasec Limited held on today i.e. Tuesday, 29h September, 2026 through Video Conferencing (‘VC)/Other Audio-Visual Means ('OAVM!') in accordance with the applicable provisions of the Companies Act, 2013 read with the Rules issued thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India. The same will be made available on the Company's website www.genpharmasec.com You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Genpharmasec Limited SOHAN SDiOguitaaNll y csriagtneudr vbeyo t (37 Cc CHATU RVEDI Date: 2026.09.29 14:42:06 +05'30° Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 Encl: as above 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com @©) +91-86555 50242 > www.genpharmasec.com CIN : L24231MH1992PLC323914 GENPHARMASEC LIMITED SUMMARY OF PROCEEDINGS OF THE 34TH ANNUAL GENERAL MEETING OF THE MEMBERS OF GENPHARMASEC LIMITED The 34th Annual General Meeting (‘AGM’) of the Members of Genpharmasec Limited was held on Tuesday, 29% September, 2026 at 11:00 am (IST). The Meeting was held via Video Conferencing (VC) / Other Audio-Visual Means (““OAVM”) in accordance with the circulars issued by the Ministry of Corporate Affairs ("MCA’) and the Securities and Exchange Board of India ('SEBI’'). The meeting commenced at 11:20 A.M (IST). Company Secretary of the company extended a warm welcome to the Shareholders present at the meeting through Video Conferencing. Mr. Sohan Chaturvedi, Chairman of the Board, chaired the Meeting. As per the Articles of Association of the Company and Section 103 of the Companies Act, 2013, the requisite quorum for the Meeting was present. Mr. Sohan Chaturvedi confirmed that the requisite quorum was present, declared the Meeting duly constituted and in order, and authorised the Company Secretary to proceed with the Meeting. The Company Secretary communicated certain points with respect to the participation in AGM. The Company Secretary further informed that all Statutory Registers and other documents related to the Ordinary and Special Businesses were made available for inspection on request. Thereafter, Company Secretary introduced the members of the Board, KMP’s, Auditors and Scrutinizer for this meeting, who were present at the meeting. The Company Secretary briefed the Members on the regulatory matters and general instructions pertaining to the AGM & E-voting. The Chairman addressed the Members and delivered his speech, by providing a brief overview of the Company’s performance and future plans. The Company Secretary then informed that the Notice of the Annual General Meeting dated 02nd September, 2026 has already been sent by electronic mode to those Members whose e-mail addresses are registered with the Company or Depositories. He then informed that the notice convening the AGM of the Company was taken as read with the permission of chairman. The following resolutions set out in the Notice convening the AGM were put to vote by remote e-Voting and e-Voting during the Meeting: Sr. No. Description of R esolution Type Of Resolutions ORDINARY BUSINESS: 1 To receive, consider and adopt the audited standalone financial Ordinary statements of the Company for the financial year ended March 31, 2026 Resolution together with the Reports of the Board of Directors’ and Auditors’ thereon. 2 To receive, consider and adopt the audited consolidated financial Ordinary statements of the Company for the financial year ended March 31, 2026 Resolution together with the Report of Auditors’ thereon. 3 To appoint a director, in the place of Mr. Sohan Chaturvedi (DIN: Ordinary 09629728) who retires by rotation and being eligible, offers himself for re- Resolution appointment. SPECIAL BUSINESS: 4 Re-appointment of Mr. Sohan Chaturvedi (DIN:-09629728), as Whole-Time Special Director of the Company for a period of 3 (Three) Years. Resolution 5 Approval for providing loans, guarantees, or security under Section 185 of Special the Companies Act, 2013. Resolution 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com @©) +91-86555 50242 > www.genpharmasec.com CIN : L24231MH1992PLC323914 GENPHARMASEC LIMITED The Company Secretary informed the Members that the facility for voting through e-voting system was made available during the Annual General Meeting for Members who had not cast their vote prior to the Meeting. The Company Secretary called the name of Members who had registered themselves as speakers to ask questions/ queries. The Company Secretary informed that Company had appointed Mr. Jaymin Modi & Co., Practising Company Secretaries, as the Scrutinizer to scrutinize the e-voting process in a fair and transparent manner. Voting results pursuant to Regulation 44(3) of the SEBI Listing Regulations and Report of the Scrutinizer, pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 will be submitted in due course. Mr. Sohan Chaturvedi thanked the Members, Board of Directors and the Auditors for their continued support and for attending the Meeting through VC/OAVM and concluded the meeting. The e-voting facility was kept open for the next 15 minutes post the conclusion of the proceedings to enable the members to cast their votes. The meeting was concluded at 11:31 A.M (IST) with a vote of thanks. We request you to kindly take the same on record and oblige. Thank you. Yours faithfully, For Genpharmasec Limited Digitally signed by SOHAN SOHAN CHATURVED Date: 2026.09.29 CHATURVEDI rc +05'30' Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com @©) +91-86555 50242 > www.genpharmasec.com CIN : L24231MH1992PLC323914